As 2025 draws to a close, it stands out as a defining year in Polymed’s journey, one marked by strategic growth, deeper global integration, and a continued commitment to strengthening healthcare delivery. In an environment shaped by evolving clinical needs, rapid technological change, and heightened expectations from healthcare systems worldwide, our focus remained clear: to build scale responsibly, invest in technology and capability, and create lasting value for patients and healthcare professionals.
Two landmark acquisitions – PendraCare and Citieffe, defined this year, significantly strengthening Polymed’s technology portfolio and expanding our global footprint. At the same time, the launch of PACE – Polymed Academy of Clinical Excellence reaffirmed our belief that technology alone is not enough; empowered and well-trained healthcare professionals are central to improving patient outcomes. Complementing these initiatives was our continued emphasis on building direct teams in key global markets, enabling deeper engagement and stronger partnerships across geographies.
The acquisitions of PendraCare and Citieffe marked a major step forward in Polymed’s long-term strategy. These were not transactional decisions, but carefully considered moves aligned with our vision of building a comprehensive, innovation-driven MedTech platform.
The acquisition of PendraCare marks a significant milestone in Polymed’s growth journey, strengthening its capabilities in the cardiology segment. This strategic addition enhances Polymed’s technology depth in advanced cardiac care, enabling the company to better address evolving clinical needs while reinforcing its commitment to innovation, quality, and patient safety.
The acquisition of Citieffe is equally significant, representing Polymed’s entry into the rapidly growing orthopaedics segment. This expansion broadens the spectrum of clinical specialties we serve and allows us to participate meaningfully in a category where innovation, precision, and long-term outcomes are critical. With Citieffe, we have added high-value technologies and deep domain expertise, further strengthening our role as a comprehensive healthcare partner.
Together, these acquisitions expand our clinical portfolio, enhance manufacturing and R&D synergies, and position Polymed to support healthcare systems across a wider continuum of care.
As global healthcare systems become more complex and increasingly outcome driven, proximity to customers and clinicians will be critical. In the year ahead, Polymed will continue to strengthen its presence by building direct teams in key international markets, reinforcing a long-term partnership approach over transactional engagement.
Direct presence allows us to understand regional clinical needs more deeply, respond faster, and provide tailored solutions supported by training, service, and technical expertise. It also enables stronger collaboration with healthcare providers, distributors, and regulatory stakeholders. This approach not only strengthens our global footprint but also enhances trust, an essential element in healthcare delivery.
While technology is at the heart of MedTech innovation, its true impact is realised only when used effectively by trained professionals. Recognising this, we launched PACE – Polymed Academy of Clinical Excellence in 2025, a key milestone that underscores our commitment to strengthening the clinical ecosystem.
PACE is designed to address skill gaps among paramedics, technicians, and frontline healthcare professionals, offering structured training, handson learning, and technology-enabled education. By focusing on correct device usage, safety protocols, and best clinical practices, PACE aims to improve patient outcomes while supporting hospitals in delivering consistent, high-quality care.
This initiative reflects our belief that skilling and upskilling are essential to sustainable healthcare transformation. As medical technologies evolve, continuous learning must evolve alongside them.
The milestones achieved in 2025 reflect Polymed’s broader philosophy: growth must be purposeful, and expansion must be anchored in capability, responsibility, and long-term value creation. Strategic acquisitions, global market strengthening, and investment in clinical excellence are all part of a cohesive roadmap designed to support patients and healthcare professionals worldwide.
As we look ahead, our focus remains on deepening innovation, strengthening partnerships, and investing in people. The healthcare challenges of tomorrow will demand not just advanced technology, but integrated solutions delivered by skilled professionals and supported by resilient global networks.
2025 has laid a strong foundation for the years ahead. With a clear vision, committed teams, and a steadfast focus on patient-centric care, Polymed is well positioned to continue contributing meaningfully to the global healthcare ecosystem.